RCE ASX Chart
Snapshot
Recce Pharmaceuticals Ltd (RCE) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of antibiotic-resistant superbugs.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -34.95% |
vs ASX 200 (1yr) | -50.14% |
Announcements
Corporate Overview
Corporate Details
Head Office | Sydney NSW 2000 |
Website | www.recce.com.au |
Registry | Automic Group |
Auditor | BDO Audit Pty Ltd |
Date Listed | 15 Jan 2016 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
29/08/2025 | Report (Prelim) |
29/08/2025 | Report (Annual) |
27/02/2026 | Report (Interim) |
Former Company Names
- Recce Limited (RCE), 16/01/2018
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
RCE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of RCE directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
HSBC Custody Nominees (Australia) Limited | 29/08/2024 | 14,970,467 | 6.46 |
FIL Limited | 29/08/2024 | 15,144,466 | 6.54 |
Graham John Hamilton Melrose & Olga Mary Melrose | 29/08/2024 | 32,353,311 | 13.97 |
Gavin William Brown | 10/06/2025 | 35,731,206 | 12.39 |
FIL Limited and the entities | 03/06/2025 | 24,705,816 | 8.57 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
10-06-25 | Gavin William Brown | 17,857,143 | 7.16 | 12.39 |
03-06-25 | FIL Limited and the entities | 7,950,744 | 6.40 | 8.57 |
16-05-25 | FIL Limited and the entities | 1,610,606 | 7.69 | 6.40 |
17-04-25 | Gavin William Brown | 17,874,063 | -- | 7.16 |
26-03-25 | Macquarie Group Limited | 12,242,076 | -- | 5.28 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
17-04-25 | Macquarie Group Limited | 12,242,076 | 5.28 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.60 | 28 June |
2023 | $0.625 | 30 June |
2022 | $0.89 | 30 June |
2021 | $0.93 | 30 June |
2020 | $0.67 | 30 June |
2019 | $0.215 | 28 June |
2018 | $0.19 | 29 June |
2017 | $0.205 | 30 June |
2016 | $0.25 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.